Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coherus Oncology (CHRS) Tax Rate (2019 - 2023)

Coherus Oncology's Tax Rate history spans 3 years, with the latest figure at 0.95% for Q3 2023.

  • For Q3 2023, Tax Rate changed N/A year-over-year to 0.95%; the TTM value through Dec 2023 reached 0.16%, changed N/A, while the annual FY2023 figure was 0.16%, N/A changed from the prior year.
  • Tax Rate for Q3 2023 was 0.95% at Coherus Oncology, up from 0.9% in the prior quarter.
  • Across five years, Tax Rate topped out at 2.56% in Q1 2020 and bottomed at 0.9% in Q4 2020.
  • The 3-year median for Tax Rate is 0.95% (2023), against an average of 1.06%.
  • The largest YoY upside for Tax Rate was 197bps in 2020 against a maximum downside of -114bps in 2020.
  • A 3-year view of Tax Rate shows it stood at 1.79% in 2019, then crashed by -150bps to 0.9% in 2020, then skyrocketed by 206bps to 0.95% in 2023.
  • Per Business Quant, the three most recent readings for CHRS's Tax Rate are 0.95% (Q3 2023), 0.9% (Q4 2020), and 0.65% (Q3 2020).